|
|
Par Pharmaceutical and its team of dedicated healthcare professionals bring new, high-quality products to market that are the therapeutic equivalent of the brand-name pharmaceuticals. Our generic drug portfolio consists of numerous products across a wide range of therapeutic areas. We are focused on niche, high-barrier-to-entry products that have limited competition and long life cycles.
- Founded in 1978, today the #5 ranked US generic company*
- Employs more than 400 professionals in offices in Woodcliff Lake, New Jersey (Corporate Headquarters); Spring Valley, New York (Research & Development and Manufacturing); and Suffern, New York (Distribution)
- An experienced Authorized Generics partner of choice for many of the world’s leading pharmaceutical companies
- Has introduced generic versions of several major pharmaceutical products, including Accupril, Dostinex, Flonase, Inderal LA, Megace OS, Paxil, Prozac, Toprol-XL and Ultracet
- Conducts manufacturing in the United States and markets and/or licenses more than 60 prescription drug product families
- Has manufacturing plant capacity of more than 2 billion tablets per year
- Strong distribution relationships in place at top US retail chains, wholesalers, distributors, managed care organizations, mail order pharmacies and group purchasing organizations
- Operational excellence in quality and compliance; achieved 97% trade-service levels
|
|
